↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

88 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 Ana001xhcl (syntagon) or vexa-04 (patheon) - - - - 1件: 156 💬
2 Behavioral: clinical characteristics of ams patients - - - - 1件: 17 💬
3 Behavioral: pat sessions - - - - 1件:  6  💬
4 Behavioral: physical activity together for pwms and their cgs (pat-ms) - - - - 1件: 13 💬
5 Biil 284 bs, high dose, adult patients - - - - 1件: 299 💬
6 Biil 284 bs, high dose, pediatric patients - - - - 1件: 299 💬
7 Biil 284 bs, low dose, adult patients - - - - 1件: 299 💬
8 Biil 284 bs, low dose, pediatric patients - - - - 1件: 299 💬
9 Biil 284 bs, medium dose, adult patients - - - - 1件: 299 💬
10 Biil 284 bs, medium dose, pediatric patients - - - - 1件: 299 💬
11 Buprenorphine transdermal patch Buprenorphine 2件: D00836, D07132 💬 2件: OPRK1, OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 46 💬
12 Cell-based therapy of autologous adipose derived regenerative cells transplanted intraspinally and intrathecally in als patients - - - - 1件:  2  💬
13 Cf patients with a g551d mutation and treated with ivacaftor Ivacaftor 1件: D09916 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 1件: 299 💬
14 Cryopreserved efs-ada lv transduced patient cd34+ cells - - - - 1件: 65 💬
15 Cryopreserved g2scid lentiviral vector transduced patient cd34+ cells - - - - 1件: 65 💬
16 Device: smartpill motility system & pillcam patency capsule - - - - 1件: 299 💬
17 Diagnostic test: blood drawing in patients with was - - - - 1件: 65 💬
18 Dietary supplement for pku patients - - - - 1件: 240 💬
19 Ef1as-ada lentiviral vector transduced patient cd34+ cells - - - - 1件: 65 💬
20 Etims (edc-fixed autologous pbmcs coupled with 7 immunodominant myelin peptides in ms patients) - - - - 1件: 13 💬
21 Ex vivo culture and transduction of the patient's autologous cd34+ hsc with lentivirus vector vsv-g pseudotyped cl20- 4i-ef1a-hyc-opt vector - - - - 1件: 65 💬
22 Exelon 4.6 mg/24 h transdermal patch - - - - 1件:  6  💬
23 Exelon 9.5 mg/24 h transdermal patch - - - - 1件:  6  💬
24 Exelon patch - - - - 1件:  6  💬
25 Exelon patch (rivastigmine transdermal system) Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
26 Exelon path transdermal - - - - 1件:  6  💬
27 Fentanyl transdermal patch Fentanyl 2件: D00320, D01399 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 46 💬
28 Gamma-secretase/notch signalling pathway inhibitor ro4929097 - - - - 1件: 74 💬
29 Golimumab 50 mg in patients <80 kg and golimumab 100 mg in patients >80 kg Golimumab 1件: D04358 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 97 💬
30 Growth hormone replacement therapy in growth hormone deficient patients only. Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 78 💬
31 Hp-3000 (ropinirole hydrochloride patch) Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
32 Hp-3000(ropinirole hydrochloride patch) Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
33 Intervention for incipient patients at low risk of disease progression - - - - 1件: 66 💬
34 Intervention for patients at high risk of disease progression - - - - 1件: 66 💬
35 Lidocaine patch 5% Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 13 💬
36 Long term follow up in all patients who received sar422459 in previous study tdu13583 - - - - 1件: 301 💬
37 Loxoprofen sodium hydrogel patch Loxoprofen 1件: D08149 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 271 💬
38 Neupro 2 mg/24 h transdermal patch - - - - 1件:  6  💬
39 Neupro 2mg/24 h transdermal patch - - - - 1件:  6  💬
40 Neupro 2mg/24h transdermal patch - - - - 1件:  6  💬
41 Neupro 4 mg/24 h transdermal patch - - - - 1件:  6  💬
42 Neupro 4mg/24 h transdermal patch - - - - 1件:  6  💬
43 Neupro 4mg/24h transdermal patch - - - - 1件:  6  💬
44 Neupro 4mg/24hr transdermal patch - - - - 1件:  6  💬
45 Neupro 6 mg/24 h transdermal patch - - - - 1件:  6  💬
46 Neupro 6mg/24 h transdermal patch - - - - 1件:  6  💬
47 Neupro 6mg/24h transdermal patch - - - - 1件:  6  💬
48 Neupro 8 mg/24 h transdermal patch - - - - 1件:  6  💬
49 Neupro 8mg/24h transdermal patch - - - - 1件:  6  💬
50 Nicotine patch Nicotine 3件: D03365, D05156, D05157 💬 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 2件:  6 , 84 💬
51 Nicotine transdermal patch Nicotine 3件: D03365, D05156, D05157 💬 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 1件:  6  💬
52 Observational study with patients treated with tracleer, ventavis, veletri, opsumit and/or uptravi - - - - 1件: 86 💬
53 Other: histone acetylation profiles of cells of srt patients with crebbp mutations - - - - 1件: 102 💬
54 Other: neupro 4 mg / 24 hr. transdermal patch - - - - 1件:  6  💬
55 Other: observation of ocrelizumab as treatment in rrms patients Ocrelizumab 1件: D05218 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 13 💬
56 Other: the patients' parents have to complete the vineland ii adaptive behavior scales scoring, the sleep disturbance scale for children (sdsc) and horne & ostberg circadian typology questionnaire - - - - 1件: 149 💬
57 Other: transthoracic echocardiography at rest, during plr, hg and cpx (including blood gas analysis in both groups). additionally fallot patients will undergo routine blood testings. - - - - 1件: 215 💬
58 Oxycodone by patient-controlled analgesia (pca) Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬
59 Pat - - - - 3件:  6 , 13, 160 💬
60 Pat-001, 0.1% - - - - 1件: 160 💬
61 Pat-001, 0.2% - - - - 1件: 160 💬
62 Patient current care - - - - 1件: 46 💬
63 Patient treated with dmard - - - - 1件: 46 💬
64 Patients will be randomized to receive ehp-101 - - - - 1件: 51 💬
65 Patients' existing non-steroidal anti-inflammatory drug (nsaid) at approved doses - - - - 1件: 46 💬
66 Pd patients h&y=1.5-2 medications off - - - - 1件:  6  💬
67 Pd patients h&y=1.5-2 medications on - - - - 1件:  6  💬
68 Pd patients h&y=3 medications off - - - - 1件:  6  💬
69 Pd patients h&y=3 medications on - - - - 1件:  6  💬
70 Procedure: skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 srt patients included. - - - - 1件: 102 💬
71 Procedure: speech pathology evaluation - - - - 1件: 78 💬
72 Procedure: tof repair with trans-annular patch vs preservation of pv - - - - 1件: 215 💬
73 Procedure: use of an electronic data capture system by patients and physicians to assess patient-physician interactions & therapeutic decisions & outcomes in ra subjects. Bifenthrin - - - 1件: 46 💬
74 Rituximab, observational study amon patients with active ra Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
75 Rivastigmin luye transdermal patches - 4.6mg/24h - - - - 1件:  6  💬
76 Rivastigmine luye transdermal patch- 9.5mg/24h Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
77 Rivastigmine patch 9.5 cm2 Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
78 Rivastigmine transdermal patch Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 2件:  6 , 13 💬
79 Rotigotine transdermal patch Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
80 Rotigotine transdermal patch 2mg/24h(10cm2) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
81 Rotigotine transdermal patch 4mg/24h (20cm2) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
82 Rotigotine transdermal patch 6mg/24h (30cm2) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
83 Rotigotine transdermal patch 8mg/24h (40cm2) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
84 Routine transdermal oestrogen patch - - - - 1件: 78 💬
85 The effectiveness of xeljanz in rheumatoid arthritis patients - - - - 1件: 46 💬
86 Tnf-blockers suspension in patients with rheumatoid arthritis - - - - 1件: 46 💬
87 Transduced patient cd34+ cells - - - - 1件: 65 💬
88 Treat with lansoprazole 30 mg bid for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms Lansoprazole 1件: D00355 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 1件: 98 💬

先頭へ